Julie Loader
Impact in
-
- Cancer Genomics and Diagnostics
-
- Retinal Development and Disorders
- CRISPR and Genetic Engineering
Papers in
-
- Retinal Development and Disorders 2
- TGF-β signaling in diseases 1
- Oncology 4
- Cancer Cells and Metastasis 2
- Co-authors
- Paul J. Adam (4 shared papers)Kerry Tyson (3 shared papers)Adrian L. Harris (3 shared papers)Sonal Patel (3 shared papers)Graham C. Fletcher (3 shared papers)Laurent Daviet (2 shared papers)Pierre Legrain (2 shared papers)Antonella Baron (1 shared paper)
- Journals
- Human Gene Therapy (2 papers)Gene (1 paper)British Journal of Cancer (1 paper)Molecular Therapy (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Julie Loader
11 papers receiving 830 citations
Peers
Comparison fields: 5 of 75
- Cancer Research 139
- Molecular Biology 591
- Cell Biology 135
- Oncology 222
- Spectroscopy 120
Countries citing papers authored by Julie Loader
This map shows the geographic impact of Julie Loader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Loader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Loader more than expected).
Fields of papers citing papers by Julie Loader
This network shows the impact of papers produced by Julie Loader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Loader. The network helps show where Julie Loader may publish in the future.
Co-authors
The 25 scholars most cited alongside Julie Loader, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 180 | |
| 2 | 2003 | 177 | |
| 3 | 2003 | 156 | |
| 4 | Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro. | 2003 | 89 |
| 5 | 2014 | 83 | |
| 6 | 2003 | 56 | |
| 7 | 2012 | 48 | |
| 8 | 2002 | 26 | |
| 9 | 2019 | 19 | |
| 10 | 2018 | 10 | |
| 11 | Phase I Safety and Tolerability results for RetinoStat®, a Lentiviral Vector Expressing Endostatin and Angiostatin, in Patients with Advanced Neovascular Age-Related Macular Degeneration | 2016 | 1 |
| 12 | 2015 | 0 |
About Julie Loader
Julie Loader is a scholar working on Molecular Biology, Oncology, Ophthalmology, Radiology, Nuclear Medicine and Imaging and Cellular and Molecular Neuroscience, having authored 12 papers that have together received 845 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (2 papers), Virus-based gene therapy research (2 papers), Retinal Diseases and Treatments (2 papers), Retinal Development and Disorders (2 papers), Pancreatic function and diabetes (1 paper), Hereditary Neurological Disorders (1 paper), Nerve injury and regeneration (1 paper) and TGF-β signaling in diseases (1 paper). The work is most often cited by research in Cancer Research (139 citations), Molecular Biology (591 citations), Cell Biology (135 citations), Oncology (222 citations) and Spectroscopy (120 citations). Julie Loader has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Paul J. Adam, Kerry Tyson, Adrian L. Harris, Sonal Patel, Graham C. Fletcher, Laurent Daviet, Pierre Legrain, Antonella Baron, Benoît Terris and Tatjana Crnogorac‐Jurcevic. Their work appears in journals such as Human Gene Therapy, Gene, British Journal of Cancer, Molecular Therapy and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.